Molecular and functional determinants of local anesthetic inhibition of NaChBac

被引:12
|
作者
Lee, Sora [1 ]
Goodchild, Samuel J. [1 ]
Ahern, Christopher A. [1 ]
机构
[1] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut & Cellular, Vancouver, BC V5Z 1M9, Canada
关键词
sodium channel pharmacology; structure-based drug design; NaChBac; local anesthetic binding sites; GATED SODIUM-CHANNEL; CRYSTAL-STRUCTURE; POTASSIUM CHANNEL; NA+ CHANNELS; VOLTAGE; BLOCK; ARRHYTHMIAS; ACTIVATION; MUTATIONS; LIDOCAINE;
D O I
10.4161/chan.21807
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In our recent publication, we describe the local anesthetic (LA) inhibition of the prokaryotic voltage gated sodium channel NaChBac. Despite the numerous functional and putative structural differences with the mammalian sodium channels, the data show that LA compounds effectively and reversibly inhibit NaChBac channels in a concentration range similar to resting blockade on eukaryotic Navs. In addition to current reduction, LA application accelerated channel inactivation kinetics of NaChBac which could be accounted for in a simple state-model whereby local anesthetics increase the probability of entering the inactivated state. We have further explored what state (or states) local anesthetic blockade of NaChBac could pertain to eukaryotic sodium channels, and what molecular similarities exist between these disparate channel families. Here we show that the rate of recovery from inactivation remains unaffected in the presence of local anesthetics. Further, we show that two sites that support use-dependent inhibition in eukaryotic channels, do not affect block to the same extent when mutated in NaChBac channels. The data indicate that the molecular determinants and the inherent mechanisms for LA block are likely to be divergent between bacterial and eukaryotic Navs, but future experiments will help define possible similarities.
引用
收藏
页码:403 / 406
页数:4
相关论文
共 50 条
  • [21] Molecular dynamics simulations of local anesthetic articaine in a lipid bilayer
    Mojumdar, Enamul H.
    Lyubartsev, Alexander P.
    BIOPHYSICAL CHEMISTRY, 2010, 153 (01) : 27 - 35
  • [22] Molecular determinants of local anesthetic action of beta-blocking drugs: Implications for therapeutic management of long QT syndrome variant 3
    Bankston, John R.
    Kass, Robert S.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2010, 48 (01) : 246 - 253
  • [23] MOLECULAR DETERMINANTS OF GENERAL ANESTHETIC ACTION - ROLE OF GABA-A RECEPTOR STRUCTURE
    LIN, LH
    WHITING, P
    HARRIS, RA
    JOURNAL OF NEUROCHEMISTRY, 1993, 60 (04) : 1548 - 1553
  • [25] INHIBITION OF THE TRANSTHYALKOID GRADIENT OF ELECTROCHEMICAL PROTON POTENTIAL BY THE LOCAL-ANESTHETIC DIBUCAINE
    LAASCH, H
    SCHUMANN, J
    GUNTHER, G
    PLANTA, 1991, 183 (04) : 567 - 574
  • [26] Local anesthetic inhibition of baseline potassium channels with two pore domains in tandem
    Kindler, CH
    Yost, CS
    Gray, AT
    ANESTHESIOLOGY, 1999, 90 (04) : 1092 - 1102
  • [27] Inhibition of Kv7/M Channel Currents by the Local Anesthetic Chloroprocaine
    Zhang, Fan
    Cheng, Yanxin
    Li, Hong
    Jia, Qingzhong
    Zhang, Hailin
    Zhao, Senming
    PHARMACOLOGY, 2015, 96 (3-4) : 124 - 130
  • [28] Inhibition of Ion Transport through Gramicidin A Channels by the Addition of Local Anesthetic Procaine
    Yamaguchi, Takuya
    Shirai, Osamu
    Kitazumi, Yuki
    Kano, Kenji
    ELECTROANALYSIS, 2018, 30 (02) : 304 - 309
  • [29] The search for molecular determinants of LPS inhibition by proteins and peptides
    Pristovsek, P
    Kidric, J
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (11) : 1185 - 1201
  • [30] LOCAL-ANESTHETIC INHIBITION OF F1-ATPASE AND OTHER ENZYMES
    VANDERKOOI, G
    CHIGNELL, D
    CHAZOTTE, B
    MOHDSIDEK, H
    BIOPHYSICAL JOURNAL, 1982, 37 (02) : A150 - A150